Protocol economics across the tirzepatide dose ladder
Tirzepatide programs often span more titration steps than semaglutide protocols. Ask RxFul for per-vial cost at every strength you prescribe, including maintenance doses where most of your active patients will sit. Patient program pricing set on the starting dose will compress margin once the cohort titrates up unless your quote account for the full ladder.
If you offer both GLP-1 molecules, model margin separately. Switching patients between semaglutide and tirzepatide changes COGS discontinuously — your portal pricing page should reflect two cost curves, not one average GLP line.